Extended Data Table 2 Mean differences of QoL scores in the RAT group versus the SOC arm during the RAT phase
From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
